PTEN and cancer: Perhaps the most promising preclinical candidate for restoring PTEN function is miR-21, which has been successfully silenced using antisense anti-miR oligonucleotides (AMOs) and locked nucleic acid (LNA) conjugated to lipid nanocapsules in other cancer types [121,122].